IRIS
BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.409
EU - Europa 4.008
AS - Asia 2.736
SA - Sud America 21
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 16
Totale 12.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.315
CN - Cina 1.437
SE - Svezia 967
IE - Irlanda 961
SG - Singapore 939
IT - Italia 578
UA - Ucraina 513
FI - Finlandia 325
DE - Germania 297
TR - Turchia 273
GB - Regno Unito 211
CA - Canada 94
IN - India 31
CZ - Repubblica Ceca 28
AT - Austria 21
BE - Belgio 21
NL - Olanda 21
FR - Francia 17
VN - Vietnam 17
BR - Brasile 16
CI - Costa d'Avorio 16
EU - Europa 15
ES - Italia 12
IR - Iran 12
JP - Giappone 8
HK - Hong Kong 7
LT - Lituania 7
RO - Romania 7
RU - Federazione Russa 7
HR - Croazia 3
KZ - Kazakistan 3
AR - Argentina 2
DK - Danimarca 2
IL - Israele 2
IQ - Iraq 2
MA - Marocco 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
GR - Grecia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 12.210
Salva come PNG Salva come JPEG
Città #
Chandler 1.077
Dublin 953
Singapore 714
Beijing 500
Jacksonville 496
Boardman 394
Ashburn 367
Ann Arbor 360
Izmir 264
Parma 250
Nanjing 232
Princeton 218
Dearborn 157
Wilmington 156
New York 119
San Mateo 114
Shanghai 103
Toronto 78
Kunming 70
Nanchang 67
Woodbridge 63
Shenyang 53
Santa Clara 52
Hebei 49
Helsinki 46
Hefei 44
Jiaxing 41
Milan 38
Jinan 35
Los Angeles 33
Seattle 32
Des Moines 31
Guangzhou 30
Changsha 27
Falls Church 26
Bremen 24
Tianjin 22
Brussels 21
Houston 21
Norwalk 21
Munich 19
Vienna 19
Abidjan 16
Brno 16
Dong Ket 16
Piacenza 15
Chicago 13
Dallas 13
Grafing 13
Mestre 13
Pune 13
Fremont 12
Zhengzhou 12
Chengdu 11
Hangzhou 11
Verona 11
London 10
Rome 9
Ardabil 8
Dortmund 8
Frankfurt am Main 7
Fuzhou 7
Rockville 7
Wenzhou 7
Amsterdam 6
Augusta 6
Bolzano 6
Edinburgh 6
Marseille 6
Washington 6
Atlanta 5
Bologna 5
Fairfield 5
Istanbul 5
Leawood 5
Neviano degli Arduini 5
Ningbo 5
Redwood City 5
Tappahannock 5
Tarragona 5
Assago 4
Chongqing 4
Düsseldorf 4
Fort Worth 4
Huskvarna 4
Kocaeli 4
Mumbai 4
Phoenix 4
Senigallia 4
São Paulo 4
Wuhan 4
Xian 4
Almaty 3
Borås 3
Fidenza 3
Haikou 3
Novellara 3
Ottawa 3
Padova 3
Paris 3
Totale 7.842
Salva come PNG Salva come JPEG
Nome #
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 142
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 125
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 115
Metabolomic Changes after Coffee Consumption: New Paths on the Block 108
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 105
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 102
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 102
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 95
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 95
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 94
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 92
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 91
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 91
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 89
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 88
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 87
Operation of Randle's cycle in patients with NIDDM 86
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 86
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 85
Predictors of insulin sensitivity in type 2 diabetes mellitus 84
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 84
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 83
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 83
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 82
Adipocytes IGFBP-2 expression in prepubertal obese children. 82
Pathogenesis of NIDDM. A balanced overview. 81
Beta-cell function across the spectrum of glucose tolerance in obese youth. 80
Which is the eligible patient to be treated with pioglitazone? The expert view. 80
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 79
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 78
Obesity and insulin resistance in man. A dose response study 77
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 77
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 77
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 76
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 75
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 75
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 75
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 75
Phasic insulin release and metabolic regulation in type 2 diabetes 74
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 74
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 73
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 73
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 73
A compartmental model to quantitate in vivo glucose transport in the human forearm 73
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 73
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 73
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 71
Estimation of organ transport function for recirculating indicator dilution curves 71
Fasting plasma glucose variability predicts 10-year survival of Type 2 diabetic patients. The Verona Diabetes Study 71
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 71
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 71
Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis. Prospective results from the Bruneck Study 70
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 70
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 70
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 70
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 70
Glucose and free fatty acid metabolism in human obesity. Relationship with insulin resistance 70
Time dependence of the interaction between lipid and glucose in humans 69
In vivo glucose metabolism in obese and type II diabetic subjects with and without hypertension. 69
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 69
Treatment intensification in patients with inadequate glycemic control on basal insulin: Rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 69
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 69
Effects of glucosamine infusion on insulin secretion and insulin action in humans 69
Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue 68
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 67
Plasma glucose within the normal range is not associated with carotid atherosclerosis. Prospective results in subjects with normal glucose tolerance from the Bruneck Study 67
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 67
Protein metabolism in human obesity: Relationship with glucose and lipid metabolism and with visceral adipose tissue. 67
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 66
Glucose metabolism in obesity and type 2 diabetes 66
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 66
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 66
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes 66
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 65
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man 65
Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Implications for treatment and monitoring of metabolic control 65
Bariatric surgery or medical therapy for obesity 65
Impact of Reference Category and Number of Traits in the Cluster on Risk of Coronary Heart Disease in Metabolic Syndrome: Prospective Data from the Bruneck Study. 65
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 65
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 65
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 64
Insulin sensitivity is not impaired in Mexican-American women without a family history of diabetes 64
Metabolic and hemodynamic effects of insulin on human hearts 63
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 63
Muscle glucose transport and phosphorylation in type 2 diabetic, obese non-diabetic, and genetically predisposed individuals. 63
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange 63
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 62
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 62
Metabolic and thermogenic effects of lactate infusion in humans 62
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds 62
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 61
The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. 61
Insulin causes endothelial dysfunction in humans. Sites and mechanisms 61
High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. 61
Development and validation of an analytical hplc method to assess chemical and radiochemical purity of [68ga]ga-nodaga-exendin-4 produced by a fully automated method 61
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 60
Relationship between insulin and carotid atherosclerosis in the general population: The Bruneck study 60
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study 60
Homeostasis Model Assessment (HOMA) closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity 60
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 60
Totale 7.510
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.747
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.011 0 0 0 0 145 147 191 33 131 222 42 100
2020/20211.363 4 114 173 12 134 150 136 26 226 76 205 107
2021/20221.084 92 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.399 90 136 66 50 113 334 72 96 40 49 146 207
2024/20251.412 79 303 338 312 380 0 0 0 0 0 0 0
Totale 12.654